Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study
Crossref DOI link: https://doi.org/10.1007/s00259-015-3124-4
Published Online: 2015-08-01
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Frangos, Savvas
Iakovou, Ioannis P.
Marlowe, Robert J.
Eftychiou, Nicolaos
Patsali, Loukia
Vanezi, Anna
Savva, Androulla
Mpalaris, Vassilis
Giannoula, Evanthia I.
Text and Data Mining valid from 2015-08-01